2025 HCPCS Code G9092

Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)

TAGS: recurrence adenocarcinoma initially invasive disease demonstration limited rectal evidence predominant extent metastases established

Short Description	Onc dx rectal t1-3,n1-2noprg
HCPCS Action Code	N - No maintenance for this code
HCPCS Coverage Code	C - Carrier judgment
HCPCS Code Added Date	January 01, 2006
HCPCS Action Effective Date	January 01, 2007
HCPCS Pricing Indicator Code	00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.)
HCPCS Type Of Service Code	1 - Medical care
HCPCS Multiple Pricing Indicator Code	9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99')
HCPCS Anesthesia Base Unit Quantity	0
HCPCS Coverage Issues Manual Reference Section Number